Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. News
  4. >
  5. MicroStrategy Announces Proposed Private Offering of $500 Million of Convertible Senior Notes

MicroStrategy Announces Proposed Private Offering of $500 Million of Convertible Senior Notes

Written by Emily J. Thompson, Senior Investment Analyst
stocks logo
MSTR.O-3.77%
Source: Newsfilter
Updated: Jun 13 2024
0mins
Financial AI Agent
Financial AI Agent
Source: Newsfilter
stocks logo
MSTR.O
$0.0000%Past 6 months
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
no data image
No Data
Powered By
Intellectia
Analyst Views on MSTR
Wall Street analysts forecast MSTR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MSTR is 524.08 USD with a low forecast of 425.00 USD and a high forecast of 705.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
14 Analyst Rating
Wall Street analysts forecast MSTR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MSTR is 524.08 USD with a low forecast of 425.00 USD and a high forecast of 705.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Buy
2 Hold
0 Sell
Strong Buy
Current: 186.010
sliders
Low
425.00
Averages
524.08
High
705.00
Current: 186.010
sliders
Low
425.00
Averages
524.08
High
705.00
Mizuho
Outperform -> NULL
downgrade
$586 -> $484
2025-11-10
Reason
Mizuho
Price Target
$586 -> $484
2025-11-10
downgrade
Outperform -> NULL
Reason
Mizuho lowered the firm's price target on Strategy to $484 from $586 and keeps an Outperform rating on the shares. The firm updated the company's model post the Q3 report.
Monness Crespi
Sell -> Neutral
upgrade
$NULL
2025-11-10
Reason
Monness Crespi
Price Target
$NULL
2025-11-10
upgrade
Sell -> Neutral
Reason
Monness Crespi upgraded Strategy to Neutral from Sell without a price target. The firm sees continued downside risk but says the "skew to downside pressure has meaningfully lessened" following the stock's recent selloff. Strategy's "convertible arbitrage volatility export narrative" has ended with remaining converts to be equitized in due time, the analyst tells investors in a research note. Monness believes its Sell thesis has played out.
Clear Street
Buy
downgrade
$537 -> $443
2025-11-04
Reason
Clear Street
Price Target
$537 -> $443
2025-11-04
downgrade
Buy
Reason
Clear Street lowered the firm's price target on Strategy to $443 from $537 and keeps a Buy rating on the shares. The firm remains "bullish" on bitcoin long-term, anticipating further adoption as a store of wealth, but revised bitcoin price assumptions to $125,000 from $135,000 previously, driving its target change for Strategy.
Canaccord
Buy
maintain
$464 -> $474
2025-11-03
Reason
Canaccord
Price Target
$464 -> $474
2025-11-03
maintain
Buy
Reason
Canaccord raised the firm's price target on Strategy to $474 from $464 and keeps a Buy rating on the shares. The firm said the company is almost synonymous with Bitcoin but feels the model has evolved at an accelerating rate since then, culminating to date with the highly successful rollout of minimally dilutive preferred equity. Clearly BTC spot has to trend higher for the shares to continue to work over the medium/long term, but they like the supply/demand setup for bitcoin over time.
See All Ratings
Intellectia AI SwingMax
Intellectia AI SwingMax
About MSTR
Strategy Inc., formerly MicroStrategy Incorporated, is a bitcoin treasury and business intelligence company. The Company provides cloud-native, artificial intelligence (AI)-powered enterprise analytics software to thousands of global customers. The Company’s Strategy ONE platform provides access to AI-powered workflows, unlimited data sources, cloud-native technologies, and performance to speed up time from data to action. Strategy One delivers visualization, reporting, and embedded analytics capabilities across retail, banking, technology, manufacturing, insurance, consulting, healthcare, telecommunications, and the public sector. Its Strategy Mosaic is a universal intelligence layer that provides enterprises with consistent definitions and governance across data sources, regardless of where that data resides or which tools access it. The Strategy Mosaic offers data clarity and connection by eliminating trade-offs between flexibility, control, and speed.

About the author

Emily J. Thompson
Preview
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Top News

SpaceX Targets $800 Billion Valuation in Secondary Sale

06 Dec 25
news image

U.S. Consumer Sentiment Slightly Improves in December

06 Dec 25
news image

U.S. Consumer Spending Slows in September

06 Dec 25
news image

Netflix Acquires Warner Bros. Assets in $72B Deal

05 Dec 25
news image

Related Articles

Incyte Receives FDA Breakthrough Therapy Designation for INCA033989, Transforming ET Treatment

23:30 PM
news image

Incyte Reports Promising Clinical Data for INCA033989 in Myelofibrosis Treatment

23:30 PM
news image

Sigh Up to Get Intellectia Insights

arrow icon

Why did Strategy Inc's stock decline alongside Bitcoin's value reversal?

arrow icon

What factors contributed to Strategy Inc's reduced stock price target?

arrow icon

Will Strategy Inc's $1.44 billion reserve stabilize its financial position long-term?

arrow icon

How might Bitcoin's recovery impact Strategy Inc's stock performance in 2025?

arrow icon

What does Strategy Inc's dual-reserve model indicate about its financial strategy?

People Also Watch

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free